catechin has been researched along with docetaxel anhydrous in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Wu, H; Xiao, Y; Xin, Y; Zhao, J | 1 |
Heber, D; Henning, SM; Vadgama, JV; Wang, P | 1 |
Du, Q; Fan, Z; Jiang, Y; Liao, B; Ravichandran, N; Shi, J; Xu, Y; Yin, J; Ying, H; Yu, C; Zhang, W | 1 |
Chen, ML; Huang, CM; Lai, CJ; Lin, YH; Lin, YN | 1 |
Boso, S; Freire-Garabal, M; Gago, P; García, C; Martínez, MC; Novio, S; Núñez-Iglesias, MJ; Pérez-Muñuzuri, ME; Santiago, JL | 1 |
5 other study(ies) available for catechin and docetaxel anhydrous
Article | Year |
---|---|
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
Topics: Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Quercetin; Taxoids; Tea | 2015 |
(-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Topics: Administration, Cutaneous; Animals; Catechin; Docetaxel; Drug Carriers; Drug Stability; Female; Humans; Mice; Nanoparticles; Permeability; Skin; Taxoids; Transdermal Patch; Xenograft Model Antitumor Assays | 2016 |
Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects.
Topics: Animals; Antineoplastic Agents; Catechin; Docetaxel; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Synergism; Humans; Male; Mice, SCID; Multifunctional Nanoparticles; Prostatic Neoplasms; Tumor Microenvironment | 2020 |
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.
Topics: Antineoplastic Agents; Biflavonoids; Breast Neoplasms; Catechin; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Male; MCF-7 Cells; Proanthocyanidins; Prostatic Neoplasms | 2021 |